Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2019 Dividend
May 15 2019 - 4:17PM
Business Wire
Zoetis Inc. (NYSE:ZTS) today announced the results of
shareholder voting at its 2019 Annual Meeting of Shareholders and
provided details on its third quarter 2019 dividend.
Annual Meeting of Shareholders
Zoetis held its annual meeting today in Short Hills, N.J., with
Chairman Michael B. McCallister presiding over the business portion
of the meeting and shareholder voting. Chief Executive Officer Juan
Ramón Alaix discussed the company’s strong performance in 2018 and
its strategies for continued growth and market leadership in the
global animal health industry.
The results of shareholder voting from the meeting were as
follows:
- Juan Ramón Alaix, Paul M. Bisaro, Frank
A. D’Amelio and Michael B. McCallister have been elected as
directors for three-year terms.
- Shareholders approved, on an advisory
basis, the compensation of the company’s named executive
officers.
- Shareholders ratified and approved the
selection of KPMG LLP as the company’s independent registered
public accounting firm for fiscal year 2019.
As part of his remarks about the company, Alaix said, “In 2018,
we delivered our sixth consecutive year of operational revenue
growth and increased profitability. We also made further
investments in our business, both through research and development,
as well as acquisitions and external partnerships. As we look to
the future, I am confident that we will continue to grow in line
with or faster than the market, based on the strength of our
diverse and innovative portfolio, high-quality manufacturing, and
world-class field-force.”
A full replay of the meeting will be made available at
http://investor.zoetis.com/events-presentations, along with the
presentation materials from the event.
Quarterly Dividend Declared
In separate proceedings today, the Zoetis Board of Directors
declared a third quarter 2019 dividend payable to holders of the
company’s common stock of $0.164 per share; the dividend is to be
paid on Tuesday, Sept. 3, 2019, to holders of record on Friday,
July 19, 2019.
About Zoetis
Zoetis is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more
than 65 years of experience in animal health, Zoetis discovers,
develops, manufactures and commercializes veterinary vaccines,
medicines and diagnostics, which are complemented by genetic tests,
biodevices and a range of services. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and
companion animals with sales of its products in more than 100
countries. In 2018, the company generated annual revenue of $5.8
billion with approximately 10,000 employees. For more information,
visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release contains
forward-looking statements, which reflect the current views of
Zoetis with respect to business plans or prospects, future
operating or financial performance, future use of cash and dividend
payments, and other future events. These statements are not
guarantees of future performance or actions. Forward-looking
statements are subject to risks and uncertainties. If one or more
of these risks or uncertainties materialize, or if management's
underlying assumptions prove to be incorrect, actual results may
differ materially from those contemplated by a forward-looking
statement. Forward-looking statements speak only as of the date on
which they are made. Zoetis expressly disclaims any obligation to
update or revise any forward-looking statement, whether as a result
of new information, future events or otherwise. A further list and
description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2018, including in the sections thereof captioned
“Forward-Looking Statements and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on
Form 10-Q and in our Current Reports on Form 8-K. These filings and
subsequent filings are available online at www.sec.gov,
www.zoetis.com, or on request from Zoetis.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190515005958/en/
Media:Kristen Seely1-973-443-2777
(o)kristen.seely@zoetis.comInvestors:Steve Frank1-973-822-7141
(o)steve.frank@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024